RocketTickers

TRACON Pharmaceuticals Announces FDA Approval of Amended ENVASAR

做多
TRACON Pharmaceuticals, Inc. (NASDAQ:TCON)  
RocketTickers  
NASDAQ:TCON   TRACON Pharmaceuticals, Inc.
Beyond Technical Analysis
1
1
beyondta
TCON: TRACON Pharmaceuticals, Inc.
2022-03-10 08:05:00
TRACON Pharmaceuticals Announces FDA Approval of Amended ENVASARC Protocol
免责声明

这些信息和出版物并不意味着也不构成TradingView提供或认可的金融、投资、交易或其它类型的建议或背书。请在使用条款阅读更多信息。